SupplementDrug
Catechin clinical trials
- studies test it
- 12
- open now
- 0
- in phase 3
- 0
- first study started
- 2012
How studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 2016 (3)
| Year | Studies |
|---|---|
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2019 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 4
- Phase 2
- 4
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 11
Craig McDonald, MD (3) · National Polytechnic Institute, Mexico (1) · University Ghent (1) · University of Reading (1) · Veterans Medical Research Foundation (1) · Brooklyn College of the City University of New York (1) · Danisco (1) · Wageningen University (1)
Often tested with
Tested in the same studies.
Proanthocyanidins (1) · Quercetin (1) · Ascorbic Acid (1)
Studies
Open first, then newest update. How each study uses Catechin is read from its arms, and is right about nine times in ten.
Testing it · 12
- Effects of COcoa Supplement in OBese Adolescent SubjectsCompletedNot applicableNational Polytechnic Institute, MexicoNCT04112251Written as Cocoa Flavonols Supplement
- The Influence of the Microbiome on the Pharmacokinetics of Flavan-3-olsCompletedNot applicableUniversity GhentNCT05113498Written as (-)-Epicatechin
- Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study)CompletedPhase 1/2Craig McDonald, MDNCT01856868Written as (-)-epicatechin
- Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory AdolescentsCompletedPhase 1/2Craig McDonald, MDNCT02964377Written as (+)- Epicatechin
- (-)- Epicatechin Becker Muscular DystrophyCompletedPhase 2Craig McDonald, MDNCT03236662Written as (-)-Epicatechin
- Cross-over Double-blind Intervention to Investigate the Effects of Defined Antioxidant-containing Drinks on Time Course of Antioxidant CapacityStatus unknownNot applicableNewcastle UniversityNCT02898571Written as epicatechin
- An Investigation of the Dose-dependent Vascualr Effects of (-)-Epicatechin in Healthy MenCompletedEarly Phase 1University of ReadingNCT02292342Written as Epicatechin 0.1 mg/kg
- Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin (Part 2)CompletedPhase 1Veterans Medical Research FoundationNCT02656212Written as epicatechin
- The Randomized Controlled Cocoa-Appetite TrialCompletedNot applicableBrooklyn College of the City University of New YorkNCT02408289Written as Epicatechin
- (-)-Epicatechin and Pulmonary Arterial HypertensionWithdrawnPhase 1University of California, San FranciscoNCT01880866Written as (-)-Epicatechin
- Effect of an Apple Polyphenol Extract on Brachial Artery Flow-mediated Vasodilatory FunctionCompletedPhase 2DaniscoNCT01690676Written as Epicatechin
- Study on the Effects of Epicatechin and Quercetin Supplementation on Vascular Function and Blood Pressure (FLAVO)CompletedNot applicableWageningen UniversityNCT01691404Written as Epicatechin
Codes
What other systems call Catechin · ClinicalTrials.gg INT007163
- MeSH (NLM) D002392CatechinOne source NLM
- UNII (FDA) 34PHS7TU43EPICATECHINConfirmed FDA, NLM, Wikidata
- Wikidata Q23050136(−)-epicatechinConfirmed FDA, NLM, Wikidata
- Wikidata Q415007(+)-catechinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C221986EpicatechinOne source FDA
- DrugBank DB12039One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D002392 | Catechin | One source NLM |
| UNII (FDA) | 34PHS7TU43 | EPICATECHIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q23050136 | (−)-epicatechin | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q415007 | (+)-catechin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C221986 | Epicatechin | One source FDA |
| DrugBank | DB12039 | — | One source Wikidata |
Also registered as cianidanol (UNII 8R1V1STN48 · RxNorm 1367177).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.